Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future...

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Cancer therapy resistance is a major cause of treatment failure and cancer recurrence.
• Circular RNAs (circRNAs) and N6-methyladenosine (m6A) modification are increasingly recognized for their roles in cancer progression.
• The interplay between circRNAs and m6A is a novel area of research impacting cancer therapy sensitivity.

Purpose of the Study:

• To review the current understanding of m6A modification in circRNAs.
• To elucidate the role of circRNA m6A modification in regulating cancer therapy resistance.
• To explore the mechanisms underlying the circRNA-m6A interaction in cancer resistance.

Main Methods:

• Literature review of recent studies on circRNAs, m6A modification, and cancer therapy resistance.
• Analysis of molecular mechanisms linking circRNA m6A to drug resistance.
• Synthesis of findings to identify therapeutic targets and strategies.

Main Results:

• circRNAs are dynamically regulated by m6A modification, influencing their stability and function.
• Aberrant m6A modification of circRNAs contributes to various types of cancer therapy resistance.
• The circRNA-m6A axis plays a critical role in modulating cancer cell sensitivity to chemotherapy and targeted therapy.

Conclusions:

• The m6A modification of circRNAs is a crucial determinant of cancer therapy resistance.
• Targeting the circRNA-m6A interaction presents a promising avenue for developing novel strategies to overcome drug resistance.
• Further research into these mechanisms could lead to improved cancer treatment protocols.